Women & Infants Fertility Center

Providence, Rhode Island 02903

Medical Director: Virginia A. Mensah, MD

Women & Infants Fertility Center in Providence, Rhode Island, offers comprehensive fertility care with a focus on helping you build the family you've dreamed of. Under the experienced leadership of Medical Director Dr. Virginia A. Mensah, MD, the center provides a full range of services including IVF, egg freezing, donor egg programs, and surrogacy support. Their verified lab accreditation ensures you're receiving care that meets the highest quality standards.

The center's track record speaks to their commitment to excellence, with live birth rates of 44.20% for patients under 35 and 40.80% for those ages 35-37. Having completed 991 treatment cycles in 2022, the team brings both extensive experience and a deep understanding of each patient's unique journey. When you're facing fertility challenges, it's natural to feel overwhelmed by options and statistics. Women & Infants Fertility Center focuses on providing clear guidance and personalized care, helping you navigate this important chapter with confidence and support every step of the way.

Services Offered

IVF

In vitro fertilization — eggs are retrieved and fertilized in a lab, then transferred to the uterus.

Egg Freezing

Oocyte cryopreservation — eggs are retrieved and frozen for future use.

Donor Egg

Uses eggs from a screened donor for patients who cannot use their own.

Surrogacy

Gestational carrier arrangements — an embryo is transferred to a surrogate who carries the pregnancy.

Success Rates

Success rates reflect live births per intended egg retrieval, as reported to the CDC for the 2022 reporting year. Rates vary based on individual patient factors.

Age GroupFresh TransfersFrozen TransfersNat'l Avg
Under 3544.20%-4.240.90%48.4%
35–3740.80%+4.845.10%36%
38–4024.60%+1.032.30%23.6%
Over 409.80%18.60%9.5%

Based on 991 total cycles reported. National averages computed across all reporting clinics.

Physicians

Data on this page is sourced from the CDC's National ART Surveillance System (NASS) and the Society for Assisted Reproductive Technology (SART). Success rates reflect live births per intended egg retrieval for the 2022 reporting year. Individual results vary based on patient age, diagnosis, and treatment protocol.